Updated

L'Oreal's CEO says the use of GLP-1 weight loss drugs is a very important phenomenon for the beauty industry, reported October 22, 2026. The widespread adoption of medications like Ozempic and Wegovy is affecting demand for beauty and skincare products as consumers experience weight loss and changing physical appearances. The statement reflects growing awareness within the cosmetics industry that pharmaceutical interventions are reshaping consumer spending patterns and product preferences.